medigraphic.com
Instituto Nacional de Salud Pública

2021, Number 3

<< Back Next >>

salud publica mex 2021; 63 (3)

On the increasing incidence of SARSCoV- 2 in older adolescents and younger adults during the epidemic in Mexico

Stern D, Lajous M, De la Rosa B, Goldstein E

Language: English
References: 21
Page: 422-428
PDF size: 287.01 Kb.


ABSTRACT

Objective. To estimate temporary changes in the incidence of SARS-CoV-2-confirmed hospitalizations (by date of symptom onset) by age group during and after the national lockdown. Materials and methods. For each age group g, we computed the proportion E(g) of individuals in that age group among all cases aged 10-59y during the early lockdown period (April 20-May 3, 2020), and the corresponding proportion L(g) during the late lockdown (May 18-31, 2020) and post-lockdown (June 15-28, 2020) periods and computed the prevalence ratio: PR(g)=L(g)/E(g). Results. For the late lockdown and post-lockdown periods, the highest PR values were found in age groups 15-19y (late: PR=1.69, 95%CI 1.05,2.72; post-lockdown: PR=2.05, 1.30,3.24) and 20-24y (late: PR=1.43, 1.10,1.86; post-lockdown: PR=1.49, 1.15,1.93). These estimates were higher in individuals 15-24y compared to those ≥30y. Conclusions. Adolescents and younger adults had an increased relative incidence of SARS-CoV-2 during late lockdown and post-lockdown periods. The role of these age groups should be considered when implementing future pandemic response efforts.


REFERENCES

  1. Gobierno de México. Comunicado Técnico Diario. Conferencia de prensa del 8 de junio de 2020. Mexico: Gobierno de Mexico, 2020 [cited 2020 December 12]. Available from: https://coronavirus.gob. mx/2020/06/08/conferencia-8-de-junio/

  2. Secretaría de Gobernación, Diario Oficial da la Federación. Acuerdo por el que se establecen las medidas preventivas que se deberán implementar para la mitigación y control de los riesgos para la salud que implica la enfermedad por el virus SARS-CoV2 (COVID-19). Mexico: Segob, 2020 [cited 2020 December 12]. Available from: https://www.dof. gob.mx/nota_detalle.php?codigo=5590339&fecha=24/03/2020

  3. Secretaría de Gobernación. Acuerdo por el que se establecen acciones extraordinarias para atender la emergencia sanitaria generada por el virus SARS-CoV2. Mexico: Segob, 2020 [cited 2020 December 12]. Available from: https://www.dof.gob.mx/nota_detalle.php?codigo=5590914&fec ha=31/03/2020

  4. Secretaría de Gobernación. Acuerdo por el que se establecen los Lineamientos Técnicos Específicos para la Reapertura de las Actividades Económicas. Mexico: Segob, 2020 [cited 2020 December 12]. Available from: https://www.dof.gob.mx/nota_detalle.php?codigo=5594138&fec ha=29/05/2020

  5. Backer JA, Mollema L, Vos E, Klinkenberg D, van der Klis F, de Melker H, et al. The impact of physical distancing measures against COVID-19 transmission on contacts and mixing patterns in the Netherlands: repeated cross-sectional surveys in 2016/2017, April 2020 and June 2020. MedRxiv [preprint]. 2020 [cited 2020 December 12]. Available from: https://www.medrxiv.org/content/10.1101/2020.05.18.2010150 1v1.full.pdf

  6. Zhang J, Litvinova M, Liang Y, Wang Y, Wang W, Zhao S, et al. Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China. Science. 2020;368(6498):1481-6. https://doi.org/10.1126/science.abb8001

  7. Jing QL, Liu MJ, Zhang ZB, Fang LQ, Yuan J, Zhang AR, et al. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Lancet Inf Dis. 2020;20(10):1141-50. https://doi.org/10.1016/S1473-3099(20)30471-0

  8. Public Health England. Sero-surveillance of COVID-19. UK: GOV UK, 2020 [cited 2020 December 12]. Available from: https://www.gov.uk/ government/publications/national-covid-19-surveillance-reports/serosurveillance- of-covid-19

  9. Filho LA, Landmann-Szwarcwald C, Garcia-Mateos S, Ponce de Leon ACM, de Andrade Medronho R, Gonçalves-Veloso V, et al. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil. Rev Saude Publica. 2020;54:69. https://doi.org/10.11606/s1518- 8787.2020054002643

  10. Streeck H, Schulte B, Kümmerer BM, Richter E, Höller T, Fuhrmann C, et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. MedRxiv [preprint]. 2020 [cited 2020 December 12]. Available from: https://www.medrxiv.org/content/10.1101/ 2020.05.04.20090076v2

  11. Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313-9. https://doi.org/10.1016/S0140-6736(20)31304-0

  12. Bajema KL, Wiegand RE, Cuffe K, Patel SV, Iachan R, Lim T, et al. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2021;181(4):450-60. https://doi.org/10.1001/jamainternmed. 2020.7976

  13. Herzog S, De Bie J, Abrams S, Wouters I, Ekinci E, Patteet L, et al. Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a prospective cross-sectional study of residual samples. MedRxiv [preprint]. 2020 [cited 2020 December 12]. Available from: https://www.medrxiv.org/ content/10.1101/2020.06.08.20125179v1.full.pdf

  14. Rosenberg ES, Tesoriero JM, Rosenthal EM, Chung R, Barranco MA, Styer LM, et al. Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York. MedRxiv [preprint]. 2020 [cited 2020 December 12]. Available from: https://www.medrxiv.org/content/10.1101/2020.05.25.201 13050v1.full.pdf

  15. Riley S, Eales O, Walters CE, Wang H, Ainslie KEC, Atchison C, et al. REACT-1 round 7 interim report: fall in prevalence of swab-positivity in England during national lockdown. Imp Coll London [preprint]. 2020 [cited 2020 December 12]. Available from: https://www.imperial.ac.uk/ media/imperial-college/institute-of-global-health-innovation/imperial_react1_ r7_interim.pdf

  16. Goldstein E, Lipsitch M. Temporal rise in the proportion of younger adults and older adolescents among coronavirus disease (COVID-19) cases following the introduction of physical distancing measures, Germany, March to April 2020. Euro Surveill. 2020;25(17):pii=2000596. https://doi. org/10.2807/1560-7917.ES.2020.25.17.2000596

  17. Goldstein E, Pitzer VE, O’Hagan JJ, Lipsitch M. Temporally varying relative risks for infectious diseases: implications for infectious disease control. Epidemiology. 2017;28(1):136-44. https://doi.org/10.1097/ EDE.0000000000000571

  18. Goldstein E, Nguyen HH, Liu P, Viboud C, Steiner CA, Worby CJ, et al. On the relative role of different age groups during epidemics associated with respiratory syncytial virus. J Infect Dis. 2018;217(2):238-44. https:// doi.org/10.1093/infdis/jix575

  19. Goldstein E, Lipstich M, Cevik M. On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community. J Infect Dis. 2020;223(3):362-9. https://doi.org/10.1093/infdis/jiaa691

  20. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.

  21. De Salazar PM, Gómez-Barroso D, Pampaka D, Gil JM, Peñalver B, Fernández-Escobar C, et al. Lockdown measures and relative changes in the age-specific incidence of SARS-CoV-2 in Spain. Epidemiol Infect. 2020;148:e268. https://doi.org/10.1101/2020.06.30.20143560




2020     |     www.medigraphic.com